CSR vs TECH · P/E 126, rev $261.0M vs P/E 65, rev $1.22B
Centerspace (CSR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Centerspace (CSR) is a reit - residential company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CSR revenue for 2024-12-31 was $261.0M. Net income was -$14.2M. Revenue was down 0.1% from 2023-12-31 to 2024-12-31. CSR currently screens at market cap $1.05B and trailing P/E 126.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CSR currently screens at market cap $1.05B and trailing P/E 126.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CSR and TECH stock pages for the full models.
Not investment advice.